Optonol

Miniature Surgical Implants for Glaucoma Patients

Active Acquired Startup Acquired Neve Ilan Founded 1996-01

Website ↗ LinkedIn

Optonol's flagship product, Ex-Press, is a miniature surgical implant used to lower intra-ocular pressure in patients with glaucoma. Optonol was founded as a spin-off of Jerusalem-based stent developer Medinol Ltd. Optonol was acquired by Alcon in December 2009. A year later, Alcon was acquired by Novartis.